Quick Takeaways
- CITADEL ADVISORS LLC filed SCHEDULE 13G for PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (the "Shares") (PLRX).
- Disclosed ownership: 5%.
- Date of event: 02 Feb 2026.
Quoteable Key Fact
"CITADEL ADVISORS LLC disclosed 5% ownership in PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (the "Shares") (PLRX) on 02 Feb 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Citadel Advisors LLC | 3.4% | 2,099,798 | 0 | 2,099,798 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Advisors Holdings LP | 3.4% | 2,099,798 | 0 | 2,099,798 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel GP LLC | 3.4% | 2,099,798 | 0 | 2,099,798 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities LLC | 1.5% | 913,609 | 0 | 913,609 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities Group LP | 1.5% | 942,335 | 0 | 942,335 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Citadel Securities GP LLC | 1.5% | 942,335 | 0 | 942,335 | /s/ Seth Levy | Seth Levy, Authorized Signatory | |
| Kenneth Griffin | 5% | 3,042,133 | 0 | 3,042,133 | /s/ Seth Levy | Seth Levy, attorney-in-fact* |